Cargando…
Use of Biomarkers in Screening for Cancer
BACKGROUND: Screening for premalignant lesions or early invasive disease has the potential to reduce mortality from cancer. Potential screening tests for malignancy include measurement of (bio)markers. CONTENT: The literature relevant to the use of biomarkers as screening tests for cancer was review...
Autor principal: | Duffy, Michael J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975170/ https://www.ncbi.nlm.nih.gov/pubmed/27683350 |
Ejemplares similares
-
Personalised treatment for cancer: role of biomarkers
por: Duffy, Michael J
Publicado: (2014) -
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer
por: Duffy, Michael J., et al.
Publicado: (2022) -
Lung cancer screening: the way forward
por: Field, J K, et al.
Publicado: (2008) -
Lymph node status in screen-detected cancers
por: Duffy, S W
Publicado: (2005) -
Screening and identification of key biomarkers in prostate cancer using bioinformatics
por: Li, Song, et al.
Publicado: (2020)